Literature DB >> 6360907

Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.

S J Cryz, F Fürer, R Germanier.   

Abstract

The role of Klebsiella pneumoniae capsular polysaccharide in relation to virulence in a murine burn wound sepsis model was investigated. Burn trauma markedly predisposed mice to lethal K. pneumoniae sepsis. A highly encapsulated variant (KP1-O) derived from K. pneumoniae KP1 was found to be extremely virulent for burned mice (50% lethal dose less than 10 organisms), whereas another variant (KP1-T), which possessed a much smaller capsule, was comparatively nonvirulent (50% lethal dose greater than 10(6) organisms). Production of large quantities of capsular material by KP1-O allowed for its rapid growth in vivo and persistence in the blood and liver. These traits were not demonstrated by KP1-T, which was effectively cleared after challenge.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360907      PMCID: PMC263459          DOI: 10.1128/iai.43.1.440-441.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide.

Authors:  B A BATSHON; H BAER; M F SHAFFER
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

2.  The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide.

Authors:  H BAER; L EHRENWORTH
Journal:  J Bacteriol       Date:  1956-11       Impact factor: 3.490

3.  Immunological paralysis induced in rabbits by a heavily capsulated Klebsiella strain.

Authors:  I ORSKOV
Journal:  Acta Pathol Microbiol Scand       Date:  1956

4.  Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1977-10-20       Impact factor: 1.955

Review 5.  Epidemiology of Klebsiella and hospital-associated infections.

Authors:  J Z Montgomerie
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

6.  Controlled trials of a polyvalent pseudomonas vaccine in burns.

Authors:  R J Jones; E A Roe; J L Gupta
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

7.  Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.

Authors:  P Domenico; W G Johanson; D C Straus
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.

Authors:  O R Pavlovskis; B H Iglewski; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

9.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.

Authors:  I A Holder; C G Haidaris
Journal:  Can J Microbiol       Date:  1979-05       Impact factor: 2.419

10.  Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more
  29 in total

1.  Virulence of silver-resistant mutant of Klebsiella pneumoniae in burn wound model.

Authors:  L K Gupta; R Jindal; H K Beri; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

2.  Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.

Authors:  V J Benedí; B Ciurana; J M Tomás
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.

Authors:  Adam W Jenney; Abigail Clements; Jacinta L Farn; Odilia L Wijburg; Andrew McGlinchey; Denis W Spelman; Tyrone L Pitt; Mary E Kaufmann; Lisa Liolios; Margaret B Moloney; Steven L Wesselingh; Richard A Strugnell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Morphological evidence for penetration of anti-O antibody through the capsule of Klebsiella pneumoniae.

Authors:  Y Meno; K Amako
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

5.  Antibacterial immunity of lower airways: local or localized?

Authors:  J Franĕk; J Libich; J Malina
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

6.  Purification and vaccine potential of Klebsiella capsular polysaccharides.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus.

Authors:  J C Lee; F Michon; N E Perez; C A Hopkins; G B Pier
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level.

Authors:  Yi-Chyi Lai; Hwei-Ling Peng; Hwan-You Chang
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

9.  Immunization against fatal experimental Klebsiella pneumoniae pneumonia.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Salmonella typhimurium virulence in a burned-mouse model.

Authors:  M Carsiotis; B A Stocker; I A Holder
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.